Evidence map›Paper›PMID 40375286›Full record

ArticleAlzheimer's research & therapy2025

Revealing heterogeneity in mild cognitive impairment based on individualized structural covariance network.

Xiaotong Wei, Ronglong Xiong, Ping Xu, Tingting Zhang, Junjun Zhang, Zhenlan Jin, Ling Li

Abstract read
In one paragraph

Article in Alzheimer's research & therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Xiaotong WeiMOE Key Lab for Neuroinformation, School of Life Science and Technology, The Clinical Hospital of Chengdu Brain Science Institute, University of Electronic Science and Technology of China, Chengdu, 610054, China.
Ronglong XiongMOE Key Lab for Neuroinformation, School of Life Science and Technology, The Clinical Hospital of Chengdu Brain Science Institute, University of Electronic Science and Technology of China, Chengdu, 610054, China.
Ping XuMOE Key Lab for Neuroinformation, School of Life Science and Technology, The Clinical Hospital of Chengdu Brain Science Institute, University of Electronic Science and Technology of China, Chengdu, 610054, China.
Tingting ZhangMOE Key Lab for Neuroinformation, School of Life Science and Technology, The Clinical Hospital of Chengdu Brain Science Institute, University of Electronic Science and Technology of China, Chengdu, 610054, China.
Junjun ZhangMOE Key Lab for Neuroinformation, School of Life Science and Technology, The Clinical Hospital of Chengdu Brain Science Institute, University of Electronic Science and Technology of China, Chengdu, 610054, China.
Zhenlan JinMOE Key Lab for Neuroinformation, School of Life Science and Technology, The Clinical Hospital of Chengdu Brain Science Institute, University of Electronic Science and Technology of China, Chengdu, 610054, China.
Ling LiMOE Key Lab for Neuroinformation, School of Life Science and Technology, The Clinical Hospital of Chengdu Brain Science Institute, University of Electronic Science and Technology of China, Chengdu, 610054, China. liling@uestc.edu.cn.

Funding

111 project B12027National Natural Science Foundation of China 62176045Sichuan Science and Technology Program 25NSFSC1238Sichuan Science and Technology Program YFHZ0061
6 · The paper itself

Abstract

backgroundMild cognitive impairment (MCI) is a heterogeneous disorder with significant individual variabilities in clinical and biological features. Abnormal inter-regional structural covariance suggests disruption of the brain structural network in MCI. Most studies have examined group-level structural covariance alterations while ignoring individual-level differences. Hence, we aimed to investigate the heterogeneity of MCI using individual differential structural covariance network (IDSCN) analysis.

methodsT1-weighted images of 596 MCI patients and 309 cognitively normal (CN) were collected from the ADNI database as discovery dataset, and 122 MCI and 117 CN from the OASIS-3 dataset as validation cohort. We constructed each patient's IDSCN using regional gray matter volume and applied K-means clustering analysis to identify MCI subtypes based on significantly altered covariance edges. Then, clinical features, brain structure, and gene expression profiles were evaluated for each subtype.

resultsIn the ADNI dataset, MCI patients exhibited significant alterations in structural covariance edges, mainly involving the hippocampus, parahippocampal gyrus, and amygdala. Two robust MCI subtypes were identified. Subtype 1 showed faster disease progression relative to subtype 2, which was validated in the independent OASIS-3 dataset. Significant differences between two subtypes were found in clinical cognition and biomarkers, cerebral atrophy patterns, and enriched genes for metal ion transport and neuron projection development. Finally, correlation analysis and functional annotation further revealed that the affected edges were related to cognitive performance and implicated in memory and emotion terms.

conclusionsIn summary, these findings offer new perspectives into understanding the heterogeneity of MCI and facilitate strategies for future precision medicine.

Indexed as

BrainCognitive DysfunctionAgedAged, 80 and overDisease ProgressionFemaleGray MatterHumansMagnetic Resonance ImagingMaleMiddle AgedGene expressionGray matter volumeHeterogeneityIndividual differential structural covariance networkMild cognitive impairmentSubtypes

Identifiers

PMID40375286
PMCPMC12079994

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.